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in Failing Hearts
The PI3-kinase–dependent serine/threonine protein kinase
Akt induces a physiological form of cardiac hypertrophy
with enhanced coronary angiogenesis and sustained con-
tractility on short-term activation. Shiojima et al (Am J Pathol
2012, 181:1969–1976) hypothesized that short-term Akt ac-
tivation–induced hypertrophy might improve contractile
function in failing hearts. Transient Akt signaling activation in
murine hearts with impaired contractility did attenuate contrac-
tile dysfunction and improved contractility before cardiac hy-
pertrophy development. Biological network analysis of differ-
entially expressed transcripts in a pressure overload–induced
heart failuremodel revealedmajor alterations in the expression
of cell death–associated genes, effects that were reversible on
short-term Akt activation. Downstream Akt kinase substrates
represent promising therapeutic targets for heart failure.
IFN-’s Role in Gastric Preneoplasia
Gastric adenocarcinoma, a leading cause of cancer mor-
tality worldwide, arises through a step-wise process of
inflammation and pro-inflammatory cytokine expression.
Syu et al (Am J Pathol 2012, 181:2114–2125) engineered
transgenic mice that specifically express the pro-inflam-
matory cytokine IFN- in the stomach to test its potential
role in gastric tumorigenesis. These H/K-IFN- transgenic
mice showed elevated mRNA levels for IFN- target
genes as well as the pro-inflammatory cytokines IL-6,
IL-1, and TNF-. Stomachs displayed inflammation, ex-
pansion of myofibroblasts, loss of parietal and chief cells,
spasmolytic polypeptide expressing metaplasia, and
dysplasia; undifferentiated and metaplastic epithelial
cells exhibited increased proliferation and apoptosis.
These data identify IFN- as a pivotal secreted factor that
orchestrates complex changes in inflammatory, epithe-
lial, and mesenchymal cell populations to drive pre-
neoplastic progression in the stomach.
Lipid Rafts and Breast Cancer Cell Migration
Cancer cell migration is a key early step in metastasis,
which is the main cause of breast cancer–related death.
Donatello et al (Am J Pathol 2012, 181:2172–2187) de-
scribe a novel mechanism of regulation of interaction be-
tween lipid raft–associated protein CD44 and its binding
partner ezrin in migrating breast cancer cells. In non-migrat-
ing cells, CD44 localized to lipid rafts, and ezrin localized to
non-raft compartments. Migration induction resulted in de-
creased CD44/lipid raft association, increased CD44/non-raftprotein co-localization, and increased CD44/active ezrin-ra-
dixin-moesin protein co-precipitation in non-raft compart-
ments. Pharmacological lipid disruption increased CD44/ezrin
co-precipitation and co-localization whereas enhanced CD44
retention inside lipid rafts abolished CD44/ezrin interactions.
Thus, CD44 must relocalize outside lipid rafts to drive breast
cancer cell migration.
TGF- and Cathepsins in Melanoma Invasion
Cancer and stromal cell interactions are important for can-
cer progression. Yin et al (Am J Pathol 2012, 181:2202–
2216) demonstrated that fibroblasts promote and guide
melanoma cell invasion via TGF- signaling and cysteine
cathepsins B/L. Genome-wide microarray and immunohis-
tochemical analyses demonstrated significantly increased
expression of cathepsins B/L, matrix metalloproteinase
(MMP)-1/MMP-9, and urokinase and tissue-type plasmino-
gen activator. Presence of cathepsins B/L and plasminogen
activators, but not MMP mRNA levels, correlated with me-
tastasis. The invasiveness/growth of the melanoma cells
with fibroblasts was inhibited by cell membrane–permeable
inhibitors of cathepsins B/L, but not by wide-spectrum in-
hibitors of MMPs. Cathepsin B regulated TGF- production/
signaling, which was required for fibroblast activation and
promotion of melanoma cell invasive growth, correlating
with shortened patient survival. This study provides a basis
for testing TGF- signaling and cathepsins B/L inhibitors in
therapy targeting invasive/metastatic melanoma.
Simvastatin Accelerates Wound Healing in
Diabetes
Lymphangiogenesis and angiogenesis are emerging ther-
apeutic targets as they are impaired during diabetic wound
healing. Since systematic statin use can stimulate angio-
genesis, Asai et al (Am J Pathol 2012, 181:2217–2224)
investigated whether topical application of simvastatin
could promote lymphangiogenesis and anigogenesis dur-
ing wound healing in db/db diabetic mice. Topical simva-
statin treatment of full-thickness skin wounds on the back of
diabetic mice resulted in acceleration of wound recovery,
increase in angiogenesis and lymphangiogenesis, and in-
filtration of macrophages producing vascular endothelial
growth factor-C in granulation tissues. Simvastatin directly
promoted capillary morphogenesis and exerted an antiapo-
ptotic effect on lymphatic endothelial cells in vitro. These
findings demonstrate that topical simvastatin can stimulate
lymphangiogenesis directly and indirectly via stimulation of
macrophages.
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